Press releases
- I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
- I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers
- I-Mab to Participate at the Jefferies Global Healthcare Conference
- I-MAB Filed 2023 Annual Report on Form 20-F
- I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference
- I-Mab Announces Closing of the Divestiture of Business Operations in China
More ▼
Key statistics
On Friday, I-Mab (0VY:DUS) closed at 1.69, -2.87% below its 52-week high of 1.74, set on Jun 05, 2024.
52-week range
Open | 1.70 |
---|---|
High | 1.71 |
Low | 1.69 |
Bid | 1.69 |
Offer | 1.74 |
Previous close | 1.69 |
Average volume | 120.00 |
---|---|
Shares outstanding | 80.88m |
Free float | 69.87m |
P/E (TTM) | -- |
Market cap | 148.82m USD |
EPS (TTM) | -2.43 USD |
Data delayed at least 15 minutes, as of Jun 14 2024 18:30 BST.
More ▼